Mineralys Therapeutics Inc
MLYSHealthcare|Biotechnology|USA
$28.38
-0.58 (-2.00%)
Tangible Book
$7.74
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.
Dec 2025
P3
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
NCT05968430